Bristol-Myers Squibb

12 Decision Makers · 34 Verified Contacts & Email Format

📍 New York, NYBiotechnology🗓 Est. 1887👥 Above 10001 employees

About Bristol-Myers Squibb

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Email Format

{first_name}.{last_name}@bms.com — 95.5%

sarah.smith@bms.com

{last_name}{first_letter_first_name}@bms.com — 4.5%

smiths@bms.com

Leadership & Decision Makers

Contact details of 12 Bristol-Myers Squibb decision makers

John damonti

Foundation President
  • Work email

    d******j@bms.com

Zachary Cain

Associate Director, Payer Marketing at Bristol-Myers Squibb
  • Work email

    z**********n@bms.com

Ming Lu

Vice President Clinical Pharmacology
  • Work email

    m*****u@bms.com

Gerald Masoudi

Executive Vice President, General Counsel and Corporate Secretary

Keith Usiskin

Executive Director

Jacqualyn Fouse

President and Chief Operating Officer

Robert M. Hershberg

Executive Vice President, Head of Business Development and Global Alliances

Jerome Zeldis

CEO of Celgene Global Health

Maria Palmisano

Managing Director

Roy Paul

Associate Director

Robert J. Hariri

Founder

Sol Barer

Founder

Team & Specialists

Contact details of 22 Bristol-Myers Squibb team members

Ron Behling

LinkedIn
  • Work email

    r************g@bms.com

Devin Carsdale

LinkedIn
  • Work email

    d************e@bms.com

Suketu Desai

LinkedIn
  • Work email

    s**********i@bms.com

Zelalem Demere

LinkedIn
  • Work email

    z************e@bms.com

Eva Dion

LinkedIn
  • Work email

    e******n@bms.com

Dina Akbar

LinkedIn
  • Work email

    d********r@bms.com

Jaya Saigal

LinkedIn
  • Work email

    j*********l@bms.com

Danish Sheikh

LinkedIn
  • Work email

    d***********h@bms.com

Trisha Putro

LinkedIn
  • Work email

    t**********o@bms.com

Xue Li

LinkedIn
  • Work email

    x****i@bms.com

Gianina Meltzer

Senior Manager, Regulatory Affairs (Oncology)
  • Work email

    g*************r@bms.com

Zheng Yang

Scientist
  • Work email

    z********g@bms.com

Herve Bertacchi

  • Work email

    h*************i@bms.com

Sonja Heintz

  • Work email

    s**********z@bms.com

Torsten Schanze

  • Work email

    t*************e@bms.com

Patricia Gaul

  • Work email

    p***********l@bms.com

Vanessa Mariani

  • Work email

    v****************a@bms.com

Emmanuel Chantelot

  • Work email

    e****************t@bms.com

Ha Dang

  • Work email

    h*****g@bms.com

Maribelis Ruiz

  • Work email

    m************z@bms.com

Sanna Viitanen

  • Work email

    s************n@bms.com

Richard S. Lev

Attorney

General Emails

General company emails, e.g. customer support lines

    drugsafety@celgene.com

    Unclassified inbox

    carmen.m.lopez@bms.com

    Unclassified inbox

    eduardo.uribe@bms.com

    Unclassified inbox

    sanna.viitanen@bms.com

    Unclassified inbox

    bd-onchema@bms.com

    Unclassified inbox

    bd-ct@bms.com

    Unclassified inbox

Similar Companies like Bristol-Myers Squibb

Biotechnology · New York, NY · Est. 1849 · Above 10001 employees

HQ: New York, NY

AbbVie

abbvie.com
Biotechnology · North Chicago, Illinois, United States · Est. 2013 · Above 10001 employees

HQ: North Chicago, Illinois, United States

Merck

merck.com
Biotechnology · Rahway, New Jersey, United States · Est. 1891 · Above 10001 employees · $1B–$1000B

HQ: Rahway, New Jersey, United States

Novo Nordisk

novonordisk.com
Biotechnology · Bagsværd, Hovedstaden, Denmark · Est. 1923 · Above 10001 employees · $1B–$1000B

HQ: Bagsværd, Hovedstaden, Denmark

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 21/08/2025

(212)546-4000

New York, NY

Specialization: Precision Medicine,
Legal Name: Bristol-Myers Squibb Company
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
Last Funding Type: Post-IPO Debt
Phone Number: (212)546-4000
Last Investment Activity: Mar 28, 2024
Investments Activity: Mar 28, 2024 Mar 27, 2024 Mar 26, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.